Satellite symposium1 Sponsored by Handok

8 Nov. 17:00-18:00 / Emerald Hall, 3F Chair: Sei-Hyun Baik

	Kyu Jeung Ahn Kyung Hee University, Korea		Going beyond A1c drop with vildagliptin ; smoothing out glycemic excursions

Satellite symposium2 Sponsored by Pfizer

8 Nov. 17:00-18:00 / Emerald Hall, 3F Chair: Tae Sun Park

	Chong Hwa Kim Sejong General Hospital, Korea		Recent advances in the management of diabetic peripheral neuropathy: where are we now and where to go?

Breakfast symposium1 Sponsored by Abbott

9 Nov. 07:30~08:30 / Convention Hall A, 4F Chair: Kwang Woo Lee

	Sung Hee Choi Seoul National University, Korea		How can we optimize the management for residual risks of atherosclerosis in patients with diabetes?

Breakfast symposium2 Sponsored by Novonordisk

9 Nov. 07:30~08:30 / Convention Hall B, 4F Chair: Min Young Chung

	Klaus Henning Jensen Novo Nordisk A/S		Insulin development – past, present and future

Breakfast symposium3 Sponsored by AstraZeneca

10 Nov. 07:30~08:30 / Convention Hall A, 4F Chair: Kyung-Ho Lim

	Byung-Joon Kim Konyang University, Korea		A new opportunity for patient-centric treatment

Breakfast symposium4 Sponsored by Takeda

10 Nov. 07:30~08:30 / Convention Hall B, 4F Chair: Jae Myung Yu

	Chang Beom Lee Hanyang University, Korea		What is next after metformin?

Luncheon symposium1 Sponsored by JW pharmaceutical

9 Nov. 12:20~13:40 / Convention Hall A, 4F Chair: You Hern Ahn

	Hiroaki Okazaki The University of Tokyo, Japan		Diabetic dyslipidemia – statins & beyond statins

Luncheon symposium2 Sponsored by MSD

9 Nov. 12:20~13:40 / Convention Hall B, 4F Chair: Chung Gu Cho

	Kyung Mook Choi Korea University, Korea		Advantages of incretin therapy for type 2 diabetes mellitus including Korean patients

Luncheon symposium3 Sponsored by Novartis

9 Nov. 12:20~13:40 / Convention Hall C, 4F Chair: Dong-Sun Kim

	Eun Gyoung Hong Hallym University, Korea		Evidence for vildagliptin as a therapeutic option for type 2 diabetes: efficacy considerations

Luncheon symposium4 Sponsored by Boehringer Ingelheim

9 Nov. 12:20~13:40 / Emerald Hall, 3F Chair: Dong-Seop Choi

	Young Min Cho Seoul National University, Korea		DPP-4 inhibitors: beyond glycemic control in diabetes treatment

Luncheon symposium5 Sponsored by Sanofi-aventis

10 Nov. 12:20-13:30 / Convention Hall A, 4F Chair: Ho Young Son

	Jeong Taek Woo Kyung Hee University, Korea		ORIGIN-what can we learn from this landmark trial?

Luncheon symposium6 Sponsored by Lilly

10 Nov. 12:20-13:30 / Convention Hall B, 4F Chair: Yeon-Ah Sung

	Eun Jung Rhee Sungkyunkwan University, Korea		Targeting post-prandial glucose control: metabolic and clinical implications

Luncheon symposium7 Sponsored by Daewoong

10 Nov. 12:20-13:30 / Convention Hall C, 4F Chair: Joong-Yeol Park

	Soo Lim Seoul National University, Korea		Factors predicting therapeutic efficacy of combination treatment with sitagliptin and metformin in type 2 diabetic patients: the COSMETIC study